What does CUSIP 816212302 represent in this 13F holders report?

CUSIP 816212302 is the security identifier for RNAC - Cartesian Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RNAC - Cartesian Therapeutics, Inc. - Common Stock in Q4 2023?

No institutional holders were reported for RNAC - Cartesian Therapeutics, Inc. - Common Stock in Q4 2023; review adjacent reporting periods for trend context.

Cartesian Therapeutics, Inc. - Common Stock (RNAC)

CUSIP: 816212302

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock
Shares outstanding: 26,621,699
Total 13F shares: 0
Share change: -1,200
Total reported value: $0
Price per share: $8.35
Number of holders: 0
Value change: -$1,272
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 816212302?
CUSIP 816212302 identifies RNAC - Cartesian Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 816212302:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Cartesian Therapeutics, Inc. - Common Stock (RNAC)

Q4 2023 13F Holders as of 31 Dec 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of RNAC - Cartesian Therapeutics, Inc. - Common Stock as of Q4 2023.